tert-butyl N-[(1S)-1-[4-(4-bromophenyl)-1H-imidazol-2-yl]-2-methylpropyl]carbamate, 100mg

2-Bromo-3-fluorotoluene, 97.0%, 25g

N-(4-Fluorobenzyl)-2-((R)-5-(3-methylureido)-2',4'-dioxo-2,3-dihydrospiro[indene-1,5'-oxazolidin]-3'-yl)-N-((S)-1,1,1-trifluoropropan-2-yl)acetamide, 97.0%, 5mg

3,5-Dichloro-4-ethoxypyridazine, 95.0%, 250mg

3-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-methyl-1{H}-pyrazole-5-carboxylic acid, 95.0%, 250mg

Methyl 3,5-dichlorobenzoate, 99.0%, 5g

(S)-2-((S)-2-(6-(2,5-DIOXO-2H-PYRROL-1(5H)-YL)HEXANAMIDO)-3-METHYLBUTANAMIDO)PROPANOIC ACID, 95%, 100mg

Methanol, min. 99%, for synthesis, 2.5 l, plastic packaging.

(S)-5-Bromo-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride, 95.0%, 100mg

Ammonium hexafluorophosphate, 99.0%, 25g

4-Methoxytrityl Chloride [Hydroxyl Protecting Agent]>98.0%(HPLC)(T)25g

Closing caps LABOCAP for 17/18 mm, blue 100 pcs

2-Amino-4-bromo-3-methylbenzoic acid, 95.0%, 250mg